ORIC Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.4%.

Top 25 shareholders own 91.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.62%	Pfizer Inc.	5,376,344	€45.6m	0%	no data
7.49%	Nextech Invest Ltd.	5,285,714	€44.9m	0%	7.15%
6.97%	FMR LLC	4,918,808	€41.7m	-2.11%	no data
6.85%	BlackRock, Inc.	4,830,880	€41.0m	52%	no data
6.23%	VR Adviser, LLC	4,394,527	€37.3m	0%	1.7%
5.87%	Frazier Life Sciences Management, LP	4,142,855	€35.2m	0%	1.63%
5.67%	Viking Global Investors LP	4,000,000	€33.9m	0%	0.14%
5.02%	The Column Group, LLC	3,540,777	€30.0m	0%	52.48%
4.85%	EcoR1 Capital, LLC	3,418,068	€29.0m	0%	1.03%
4.54%	The Vanguard Group, Inc.	3,199,726	€27.2m	11%	no data
4.48%	Alkeon Capital Management, LLC	3,160,112	€26.8m	2.32%	0.19%
3.2%	State Street Global Advisors, Inc.	2,256,228	€19.1m	31.5%	no data
2.84%	Commodore Capital LP	2,000,000	€17.0m	0%	1.17%
2.46%	Tavistock Life Sciences	1,732,571	€14.7m	0%	0.82%
2.15%	First Turn Management, LLC	1,515,960	€12.9m	38.1%	2.25%
2.13%	New Enterprise Associates, Inc.	1,500,000	€12.7m	0%	0.78%
1.81%	ArrowMark Colorado Holdings, LLC	1,273,522	€10.8m	-15.7%	0.14%
1.8%	Vivo Capital, LLC	1,269,676	€10.8m	49.4%	0.92%
1.73%	Geode Capital Management, LLC	1,222,692	€10.4m	34.1%	no data
1.69%	T. Rowe Price Group, Inc.	1,189,227	€10.1m	-24.1%	no data
1.53%	Silverarc Capital Management, LLC	1,075,812	€9.1m	-3.34%	2.51%
1.43%	Invus Financial Advisors, LLC	1,007,575	€8.6m	0%	10.02%
1.4%	Euclidean Capital LLC	989,410	€8.4m	0%	1.13%
1.11%	Millennium Management LLC	782,299	€6.6m	297%	0.01%
1.11%	Adage Capital Management, L.P.	780,400	€6.6m	-24.3%	0.01%